IDT to Present at J.P. Morgan Conference on May 23

SAN JOSE, Calif.--(BUSINESS WIRE)-- Integrated Device Technology, Inc. (IDT®) (NASDAQ: IDTI) today announced that it will present at the J.P. Morgan Global Technology, Media and Telecom Conference on Tuesday, May 23, 2017 at 9:20 a.m. ET in Boston, MA.

A live audio webcast of the presentation and an archive for replay will be available on the “Investor Relations” section of IDT’s website at http://ir.idt.com/. The replay will be available for 30 days after the event.

About IDT

Integrated Device Technology, Inc. develops system-level solutions that optimize its customers' applications. IDT's market-leading products in RF, high performance timing, memory interface, real-time interconnect, wireless power, and SmartSensors are among the company's broad array of complete mixed-signal solutions for the communications, computing, consumer, automotive and industrial segments. Headquartered in San Jose, Calif., IDT has design, manufacturing, sales facilities and distribution partners throughout the world. IDT stock is traded on the NASDAQ Global Select Stock Market(R) under the symbol "IDTI." Additional information about IDT can be found at www.IDT.com. Follow IDT on Facebook, LinkedIn, Twitter, YouTube and Google+.

(C) 2017, IDT. IDT and the IDT logo are trademarks or registered trademarks of Integrated Device Technology, Inc. or its wholly-owned subsidiaries around the world. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170510006461/en/

Financial Contact:
IDT Investor Relations
Suzanne Schmidt, 415-217-4962
[email protected]
or
Press Contact:
IDT Senior Director of Corporate
Marketing and Communications
Daniel Aitken, 408-574-6480
[email protected]

Source: Integrated Device Technology, Inc.

You May Also Be Interested In

• Hyundai Motor America names Steven Yandura VP of national sales
• Beazer Homes closes $400M senior notes offering due 2032
• EU approves Merck's Keytruda plus Padcev for bladder cancer